Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness.

Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. J Mol Cell Biol. 2012 Aug; 4(4):207-20.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.